logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9340493 B1

PDFFull Text
Date of Patent:
May. 17, 2016

Filed:

Mar. 24, 2014

Hydroxamic acid derivatives useful as antibacterial agents

Applicant:

Pfizer Inc., Groton, CT (US);

Inventors:

Matthew Frank Brown, Stonington, CT (US);

Charles Francis Donovan, Colchester, CT (US);

Edmund Lee Ellsworth, Vicksburg, MI (US);

Denton Wade Hoyer, Niantic, CT (US);

Timothy Allan Johnson, Vicksburg, MI (US);

Manjinder Singh Lall, East Lyme, CT (US);

Chris Limberakis, Pawatuck, CT (US);

Sean Timothy Murphy, Oceanside, CA (US);

Debra Ann Sherry, Chelsea, MI (US);

Clarke Bentley Taylor, Ann Arbor, MI (US);

Joseph Scott Warmus, Ledyard, CT (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorney:

Knobbe Martens Olson & Bear LLP

Primary Examiner:

James O Wilson

Assistant Examiner:

Ebenezer O Sackey

Int. Cl.
CPC ...
A61K 31/685 (2006.01); A61K 31/19 (2006.01); A61K 31/415 (2006.01); A61K 31/44 (2006.01); A61K 31/34 (2006.01); A61K 31/42 (2006.01); A61K 31/425 (2006.01); A61K 31/535 (2006.01); C07D 233/64 (2006.01); C07D 213/55 (2006.01); C07D 307/54 (2006.01); C07C 259/06 (2006.01); C07D 207/267 (2006.01); C07D 213/30 (2006.01); C07D 213/38 (2006.01); C07D 231/12 (2006.01); C07D 237/04 (2006.01); C07D 239/26 (2006.01); C07D 249/04 (2006.01); C07D 249/08 (2006.01); C07D 257/04 (2006.01); C07D 261/08 (2006.01); C07D 261/10 (2006.01); C07D 263/32 (2006.01); C07D 271/06 (2006.01); C07D 277/24 (2006.01); C07D 277/28 (2006.01); C07D 285/06 (2006.01); C07D 307/14 (2006.01); C07D 307/42 (2006.01); C07D 309/10 (2006.01); C07D 413/04 (2006.01); C07D 413/12 (2006.01); C07D 471/04 (2006.01); C07F 9/653 (2006.01); C07D 277/30 (2006.01);
U.S. Cl.
CPC ...
C07C 259/06 (2013.01); C07D 207/267 (2013.01); C07D 213/30 (2013.01); C07D 213/38 (2013.01); C07D 213/55 (2013.01); C07D 231/12 (2013.01); C07D 233/64 (2013.01); C07D 237/04 (2013.01); C07D 239/26 (2013.01); C07D 249/04 (2013.01); C07D 249/08 (2013.01); C07D 257/04 (2013.01); C07D 261/08 (2013.01); C07D 261/10 (2013.01); C07D 263/32 (2013.01); C07D 271/06 (2013.01); C07D 277/24 (2013.01); C07D 277/28 (2013.01); C07D 277/30 (2013.01); C07D 285/06 (2013.01); C07D 307/14 (2013.01); C07D 307/42 (2013.01); C07D 307/54 (2013.01); C07D 309/10 (2013.01); C07D 413/04 (2013.01); C07D 413/12 (2013.01); C07D 471/04 (2013.01); C07F 9/653 (2013.01); C07C 2101/04 (2013.01);
Abstract

The invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof, thereof, wherein: and pharmaceutically acceptable salts, prodrugs, hydrates, or solvates, thereof, wherein A, B, L-L, A, B, R-R, and m are as defined herein. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and their use in treating a bacterial infection.

Find Patent Forward Citations

Loading…